Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-03-27
2007-03-27
Gitomer, Ralph (Department: 1657)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S017000
Reexamination Certificate
active
10519465
ABSTRACT:
PAK4 and JIK, both of which bind to MKK7 and directly phosphorylate MKK7, were found in the present invention. The present invention provides an inhibitor of c-Jun phosphorylation caused by JNK3 and a method for inhibiting the same, and an agent for preventing and/or treating a disorder attributable to c-Jun phosphorylation caused by JNK3 and a method for preventing and/or treating the same, all of which comprise inhibiting one member selected from the following: the binding of PAK4 to MKK7, the phosphorylation of MKK7 by PAK4, the binding of JIK to MKK7, and the phosphorylation of MKK7 by JIK. Further, the present invention provides a method for identifying a compound that inhibits the binding of PAK4 to MKK7, the phosphorylation of MKK7 caused by PAK4, the binding of JIK to MKK7, or the phosphorylation of MKK7 caused by JIK, as well as the compound obtained thereby. Furthermore, the present invention provides a pharmaceutical composition containing an effective amount of at least one member selected from the group consisting of the aforementioned compound and the aforementioned inhibitor.
REFERENCES:
patent: 6465618 (2002-10-01), Nishida et al.
patent: 2004/0121398 (2004-06-01), Doi et al.
Xie et al., “Crystal structure of JNK3: a kinase implicated in neuronal apoptosis,”Structure, 1998, vol. 6, No. 8, pp. 983-991.
Ikeda et al., “Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c Jun NH2-Therminal kinase pathway,”Journal of Biochemistry, 2001 No. 130, pp. 773-781.
Yamauchi et al., “Differential regulation of mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7) by signaling from G protein β γ sub-unit in human embroyonal kidney 293 cells,”The Journal of Biological Chemistry, 1999, No. 274, vol. 4, pp. 1957-1965.
Yao et al., Activation of stress-activated protein kinases/c-Jun n-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase (MKK7),The Journal of Biological Chemistry, 1997, vol. 272, No. 51, pp. 32378-32383.
Tournier et al., “The MKK7 gene encodes a group of c-Jun NH2-Terminal kinase kinases,”Molecular and Cellular Biology, 1999, vol. 19, No. 2, pp. 1569-1581.
Chen et al., “Mammalian c-Jun N-terminal kinase pathway and STE20-related kinases,”Gene Therapy and Molecular Biology, 1999, vol. 4, pp. 83-98.
Dan et al., “The Ste20 group kinases as regulators of MAP kinase cascades,”Trends in Cell Biology, 2001, vol. 11, No. 5, pp. 220-230.
Eilers et al., “Role of the Jun kinase pathway in the regulation of c-Jun Expression and Apoptosis in Sympathetic Neurons,”J. Neurosci., 1998, vol. 18, No. 5, pp. 1713-1724.
Ham et al., “A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death,”Neuron, 1995, vol. 14, pp. 927-939.
Yang et al., “Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene,”Nature, 1997, vol. 389, pp. 865-870.
Moriguchi et al., “A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses,”Embo. J., 1997, vol. 16, No. 23, pp. 7045-7053.
Foltz et al., “Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli,”J. Biol. Chem., 1998, vol. 273, No. 15, pp. 9344-9351.
Yang et al., “Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity,”Proc. Natl. Acad. Sci. U.S.A., 1997, vol. 94, No. 7, pp. 3004-3009.
Bagrodia et al., “Cdc42 and PAK-mediated signaling leads to jun kinase and p38 mitogen-activated protein kinase activation,”J. Biol. Chem., 1995, vol. 270, No. 47, pp. 27995-27998.
Brown et al., “Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway,”Curr. Biol., 1996, vol. 6, No. 5, pp. 598-605.
Frost, et al., “Actions of Rho family small G proteins and P21-activated protein kinases on mitogen-activated protein kinase family members,”Mol. Cell. Biol., 1996, vol. 16, No. 7, pp. 3707-3713.
Abo et al., “PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia,”Embo J., 1998, vol. 17, No. 22, pp. 6527-6540.
Bazenet et al., “The small GTP-binding protein Cdc42 is required for nerve growth factor withdrawal-induced neuronal death,”Proc. Natl. Acad. Sci. U.S.A., 1998, vol. 95, pp. 3984-3989.
Urano et al., “IRE1 and efferent signaling from the endoplasmic reticulum,”J. Cell Sci., 2000, vol. 113, pp. 3697-3702.
Urano et al., “Coupling of stress in the ER to Activation of JNK protein kinases by transmembrane protein kinase IRE1,”Science, 2000, vol. 287, pp. 664-666.
Yoneda et al., “Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress,”J. Biol. Chem., 2001, vol. 276, No. 17, pp. 13935-13940.
Tassi et al., “Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor,”J. Biol. Chem., 1999, vol. 274, No. 47, pp. 33287-33295.
Zhang et al., “Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways,”Biochem. Biophys. Res. Commun., 2000, vol. 274, pp. 872-879.
Zhang et al., “Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine,”Biochem. Biophys. Res. Commun., 2001, vol. 289, pp. 718-724.
Cell Technologies, 2001, vol. 20, No. 11. (with partial English translation).
International Preliminary Examination Report for PCT/JP2003/008179 (English translation).
Doi Hirofumi
Hosogi Shinya
Wada Naoya
Daiichi Pharmaceutical Co. Ltd.
Gitomer Ralph
Kilyk & Bowersox P.L.L.C.
Shen Bin
LandOfFree
MKK7 activation inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with MKK7 activation inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MKK7 activation inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3796817